Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy+β-blocker for prevention of variceal rebleeding

Hepatology

Volumn 63, Issue 2, 2016, Pages 581-589

  Holster, I Lisanne ^a   Tjwa, Eric T T L ^a,f   Moelker, Adriaan ^a   Wils, Alexandra ^a   Hansen, Bettina E ^a   Vermeijden, J Reinoud ^b   Scholten, Pieter ^c   van Hoek, Bart ^d   Nicolai, Jan J ^e   Kuipers, Ernst J ^a   Pattynama, Peter M T ^a   van Buuren, Henk R ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b MEANDER MEDICAL CENTER   (Netherlands)

^c ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HAGA HOSPITAL   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ENBUCRILATE; IODINATED POPPYSEED OIL; OCTREOTIDE; POLITEF; PROPRANOLOL; SOMATOSTATIN; TERLIPRESSIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DEATH; DRUG DOSE TITRATION; ENDOSCOPIC THERAPY; ENDOSCOPIC VARICEAL LIGATION; ESOPHAGEAL LIGATOR; ESOPHAGUS VARICES BLEEDING; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEPATIC ENCEPHALOPATHY; HUMAN; INTERMETHOD COMPARISON; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; STENT; TIPS ENDOPROSTHESIS; TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT; TREATMENT FAILURE; TREATMENT OUTCOME; CLINICAL TRIAL; COMPARATIVE STUDY; COMPLICATION; DEVICES; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL HEMORRHAGE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; PROSTHESIS DESIGN; RECURRENT DISEASE;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; COMBINED MODALITY THERAPY; ENDOSCOPY, GASTROINTESTINAL; ESOPHAGEAL AND GASTRIC VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HUMANS; MALE; MIDDLE AGED; POLYTETRAFLUOROETHYLENE; PORTASYSTEMIC SHUNT, TRANSJUGULAR INTRAHEPATIC; PROSTHESIS DESIGN; RECURRENCE; STENTS; TREATMENT FAILURE;

EID: 84956795039     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28318     Document Type: Article

References (17)

1. Garcia-Tsao G, Bosch J. Management of varices and variceal hemorrhage in cirrhosis. N Engl J Med 2010;362:823-832.
2. Viviane A, Alan BN. Estimates of costs of hospital stay for variceal and nonvariceal upper gastrointestinal bleeding in the United States. Value Health 2008;11:1-3.
3. de Franchis R, Baveno VF. Revising consensus in portal hypertension: report of the Baveno V consensus workshop on methodology of diagnosis and therapy in portal hypertension. J Hepatol 2010;53:762-768.
4. Holster IL, Polinder S, Moelker A, Van Buuren HR, Kuipers EJ. A cost study of covered transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic treatment for secondary prevention of gastro-oesophageal variceal bleeding. Abstract no: Tu1059. In: Digestive Disease Week 2012, May 19-22, 2012, San Diego, CA.
5. Rossle M, Haag K, Ochs A, Sellinger M, Noldge G, Perarnau JM, et al. The transjugular intrahepatic portosystemic stent-shunt procedure for variceal bleeding. N Engl J Med 1994;330:165-171.
6. Khan S, Tudur Smith C, Williamson P, Sutton R. Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis. Cochrane Database Syst Rev 2006;(4):CD000553.
7. Bureau C, Garcia-Pagan JC, Otal P, Pomier-Layrargues G, Chabbert V, Cortez C, et al. Improved clinical outcome using polytetrafluoroethylene-coated stents for TIPS: results of a randomized study. Gastroenterology 2004;126:469-475.
8. Monescillo A, Martinez-Lagares F, Ruiz-del-Arbol L, Sierra A, Guevara C, Jimenez E, et al. Influence of portal hypertension and its early decompression by TIPS placement on the outcome of variceal bleeding. Hepatology 2004;40:793-801.
9. Garcia-Pagan JC, Di Pascoli M, Caca K, Laleman W, Bureau C, Appenrodt B, et al. Use of early-TIPS for high-risk variceal bleeding: results of a post-RCT surveillance study. J Hepatol 2013;58:45-50.
10. Rudler M, Cluzel P, Corvec TL, Benosman H, Rousseau G, Poynard T, Thabut D. Early-TIPSS placement prevents rebleeding in high-risk patients with variceal bleeding, without improving survival. Aliment Pharmacol Ther 2014;40:1074-1080.
11. Garcia-Pagan JC, Caca K, Bureau C, Laleman W, Appenrodt B, Luca A, et al. Early use of TIPS in patients with cirrhosis and variceal bleeding. N Engl J Med 2010;362:2370-2379.
12. de Franchis R, Pascal JP, Ancona E, Burroughs AK, Henderson M, Fleig W, et al. Definitions, methodology and therapeutic strategies in portal hypertension. A Consensus Development Workshop, Baveno, Lake Maggiore, Italy, April 5 and 6, 1990. J Hepatol 1992;15:256-261.
13. Opolon P, Rapin JR, Huguet C, Granger A, Delorme ML, Boschat M, Sausse A. Hepatic failure coma (HFC) treated by polyacrylonitrile membrane (PAN) hemodialysis (HD). Trans Am Soc Artif Intern Organs 1976;22:701-710.
14. Firth D. Bias reduction of maximum-likelihood-estimates. Biometrika 1993;80:27-38.
15. Pomier-Layrargues G, Villeneuve JP, Deschenes M, Bui B, Perreault P, Fenyves D, et al. Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial. Gut 2001;48:390-396.
16. Escorsell A, Banares R, Garcia-Pagan JC, Gilabert R, Moitinho E, Piqueras B, et al. TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial. Hepatology 2002;35:385-392.
17. Burroughs AK, Triantos CK. Predicting failure to control bleeding and mortality in acute variceal bleeding. J Hepatol 2008;48:185-188.